An Efficacy of Simulator Training for Fiberbronchoscopy in Intensivists

Study Overview
=================
Brief Summary
-----------------
We evaluated the effects of different fiberbronchoscopy training in how to teach and assess performance. Resident participants with no experience of fiberbronchoscopy, and doctors with little clinical experience with fiberbronchoscopy were eligible for the study.

Detailed Description
-----------------
Participants who passed the theory test were enrolled in the study, and two training simulators for fiberbronchoscopy were used. After randomization, participants were enrolled in Group A (Bronchoscopy training simulator LM-092 )and Group B(The BRONCH Mentor). The test will be taken after practice at the appropriate time.

Official Title
-----------------
An Efficacy of Simulator Training for Fiberbronchoscopy in Intensivists

Conditions
-----------------
Simulator Training

Intervention / Treatment
-----------------
* Device: Bronchoscopy training simulator LM-092 (Koken Co., Ltd, Tokyo, Japan)
* Device: The BRONCH Mentor (Simbionix, GI-Bronch Mentor, USA)


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Doctors with little experience of fiberbronchoscopy Exclusion Criteria: Resident participants who can not complete the study. Resident participants who can not pass the theroy examination.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Other
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Active Comparator: Bronchoscopy training simulator<br>Bronchoscopy training simulator LM-092 (Koken Co., Ltd, Tokyo, Japan) was used to train the participants. | Device: Bronchoscopy training simulator LM-092 (Koken Co., Ltd, Tokyo, Japan)<br>* Participants who passed the theory test and was enrolled in this group will use this device to practice. After the appropriate time of practice, the test will be taken to evaluate the efficacy.<br>|
| Experimental: The BRONCH Mentor<br>Group B: The BRONCH Mentor (Simbionix, GI-Bronch Mentor, USA) was used. | Device: The BRONCH Mentor (Simbionix, GI-Bronch Mentor, USA)<br>* Participants who passed the theory test and was enrolled in this group will use this device to practice. After the appropriate time of practice, the test will be taken to evaluate the efficacy.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Final score for examination by Bronchoscopy training simulator | Final score of manipulation, orientation, anatomy and actual operation | through study completion, an average of 3 months | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| % time at mid-lumen for fiberbronchoscopy manipulation by Bronchoscopy training simulator | % time at mid-lumen for fiberbronchoscopy manipulation by Bronchoscopy training simulator | through study completion, an average of 3 months | 
| % time at mid-lumen | % time at mid-lumen | through study completion, an average of 3 months | 
| % time at mid-lumen for fiberbronchoscopy manipulation | % time at mid-lumen for fiberbronchoscopy manipulation | through study completion, an average of 3 months | 
| Total wall hits for fiberbronchoscopy manipulation by Bronchoscopy training simulator | Total wall hits for fiberbronchoscopy manipulation by Bronchoscopy training simulator | through study completion, an average of 3 months | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Fiberbronchoscopy, Simulation, Assessment, Validity